Page 36 - Read Online
P. 36

Marasco et al. Hepatoma Res 2020;6:32  I  http://dx.doi.org/10.20517/2394-5079.2019.54                                          Page 5 of 17


               Table 2. Studies evaluating ICG in predicting PHLF
               Authors          Country  Population Etiology  Outcome  Nr. cases Technique  ICG cut-off  AUROC
               Kitano et al. [63] , 1997  Japan  54  N/A  Hospital mortality  7  ICG-r15  14%       N/A
               Lau et al. [58] , 1997  Hong Kong  127  N/A  Death        14    ICG-r15  14% (major hep.)  N/A
                                                                                       23% (minor hep.)
               Lam et al. [57] , 1999  Hong Kong  117  N/A  Postoperative   N/A  ICG-r15  14%       N/A
                                                          complications
               Hsia et al. [64] , 2000  Taiwan  168  Mixed  Morbidity    51    ICG-r15  <10% / >20%  N/A
                                                          Death          3
               Lao et al. [65] , 2005  China  255  N/A    Decompensation  N/A  ICG-r15  10-20%      N/A
               Zou et al. [37] , 2018  China  473  85% HBV  PHLF         50    ICG-r15  N/A         0.668
               Hwang et al. [66] , 2015  South Korea  723  81% HBV  Death from PHLF  6  FRL-kICG  <0.05  N/A
               Wang et al. , 2018  China    185   83% HBV  Severe PHLF   23    ICG-r15  7.1%        0.724
                       [8]
               Kim DK et al. [67]  2018  South   73  Mixed  PHLF         18    ICG-PDR  N/A         0.748
                               Korea
               Wang et al. [68] , 2019  China  35  Mixed  PHLF           16    Intra-  13.8% (day 1)  0.540
                                                          Day 1-3-5            operative   13.8% (day 3)  0.800
                                                                               ICG-r15  22.7% (day 5)  0.910
               ICG: Clearance of Indocyanine green; ICG-r15: ICG 15 min retention test; FRL-kICG: ICG constant fraction of future remnant liver; ICG-
               PDR: ICG-plasma disappearance rate; hep: hepatectomy; HBV: hepatitis B virus; N/A: not available; PHLF: post-hepatectomy liver failure


               Germany), was developed. The device uses a finger optical probe, which detects, after ICG infusion, the
               fractional pulsatile changes in optical absorption. The device has already been validated in several studies [50,51]

                                                                                                 [50]
               with good correlation with ICG-r15results, comparable with correction of a mathematical formula .
                                                                                        [48]
               Since ICG clearance depends on blood flow, it was associated with portal hypertension  and liver function
               for its pharmacokinetics (uptake and excretion through the hepatocytes) as well [47,52-54] . Thus, in Eastern
               countries it is considered an accurate method to assess liver functional reserve pre-operatively and has been
                                   [47]
               used for almost 30 years ; on the other hand, in Western countries, it is not widely used because it is highly
                                          [47]
               influenced by hepatic blood flow  and thus, by other conditions that could affect it.
               The normal ICG-r15 value is about 10% . The ICG-r15 reported cut-off for performing a safe major
                                                   [55]
               hepatectomy is between 14% and 17%, the latter in younger patients with milder liver disease [56,57] .
               Other authors have reported different cut-offs of 14% and 23% for safe major and minor hepatectomy
                                                     [57]
               respectively [55,58] . In another previous study  with age and sex-matched patients, the authors found no
               difference in terms of PHLF and mortality between patients with ICG-r15 of more than, and less than
               14% who have undergone major hepatectomy. However, to date, the reported upper limit of ICG-r15 for
                                            [59]
               considering liver resection is 40% . The accuracy of ICG-r15 in predicting PHLF could be increased with
                                                       [59]
               the combination of bilirubin levels and ascites . Several authors comparing the performance of ICG-r15
                                                                 [60]
               with other parameters found that it was superior to MELD  and that the combination with platelet count,
                                                                                              [8]
               portal hypertension (ICG-r15 cut-off value of 7.1%, sensitivity 52.2% and specificity 89.5%)  and Child-
               Pugh stage  was able to improve its accuracy. Moreover, liver stiffness measurement (LSM) was also found
                        [61]
                                                                                                  [62]
               to correlate with ICG-r15 and to provide additional information on the prognosis of the patient . Other
               authors have found good correlation when comparing ICG-r15 with the degree of portal hypertension [48,54] .
               In conclusion, no definitive lower ICG-r15 cut-offs for distinguishing between safe minor or major
               hepatectomy are currently available, as shown in Table 2 [8,37,57,58,63-67] ; major hepatectomy in the presence
               of unsatisfactory ICG-r15 results should be performed only in high-volume centers. ICG-r15 could be
               considered a good marker of liver function and indirectly, of the degree of portal hypertension. Further
               studies are needed however, for this latter association.

               Portal hypertension scores
               Plated to spleen stiffness ratio PSR
               Another widely used biochemical score is the PSR (platelet count-to-spleen ratio), which consists of the
                                                       3
                                                                                 [69]
               ratio between PLT (expressed in number/mm ) and spleen diameter (mm) . The PSR value is strictly
   31   32   33   34   35   36   37   38   39   40   41